Each unit consists of one ordinary share and one-half of a Series A Warrant to purchase one ordinary share. When trading begins on March 18, the ordinary shares and Series A Warrants will trade separately on the Nasdaq Capital Market under the symbols “CHEK” and “CHEKW” respectively.
Check-Cap is a clinical stage medical diagnostics company focused on the development of gastrointestinal imaging devices, including a preparation-free ingestible imaging capsule.
More articles on GI/endoscopy:
The Endoscopy Center to sign pledge for increasing CRC screening rates nationwide
Olympus faces 5 lawsuits in wake of UCLA outbreak
Dr. Daniel Podolsky to join Agilent Technologies board of directors
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
